Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
101 studies found for:    Medivation
Show Display Options
Download search resultsDownload the search results for:
Medivation (101 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo;   Drug: Paclitaxel
2 Recruiting A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Conditions: Prostate Carcinoma Metastatic to the Bone;   Castration Resistant Prostate Cancer
Intervention: Drug: Enzalutamide
3 Recruiting Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Conditions: Hormone Sensitive Prostate Cancer;   Prostate Cancer;   Cancer of the Prostate
Interventions: Drug: Enzalutamide;   Drug: Placebo;   Drug: Leuprolide
4 Recruiting Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Conditions: Nonmetastatic Castration-Resistant Prostate Cancer;   Prostate Cancer;   Cancer of the Prostate
Interventions: Drug: Enzalutamide;   Drug: Placebo
5 Recruiting A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
Conditions: Breast Neoplasms;   BRCA 1 Gene Mutation;   BRCA 2 Gene Mutation
Interventions: Drug: talazoparib;   Drug: Physician's-Choice
6 Recruiting Open-Label Extension and Safety Study of Talazoparib
Condition: Cancer
Intervention: Drug: Talazoparib
7 Recruiting A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: Talazoparib;   Drug: Itraconazole;   Drug: Rifampin
8 Recruiting A Study of Talazoparib in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: Talazoparib
9 Recruiting A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors
Condition: Solid Tumor
Intervention: Drug: Talazoparib
10 Recruiting An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
Condition: Advanced Solid Tumors
Intervention: Drug: Talazoparib
11 Not yet recruiting An Open-Label Pharmacokinetics and Safety Study of Talazoparib
Condition: Advanced Solid Tumors
Intervention: Drug: Talazoparib
12 Recruiting A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Condition: Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: abiraterone acetate;   Drug: prednisone
13 Withdrawn A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer
Condition: Ovarian Cancer
Interventions: Drug: Talazoparib;   Drug: Temozolomide
14 Active, not recruiting Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: exemestane;   Drug: Placebo (for enzalutamide)
15 Active, not recruiting Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
Condition: Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
Intervention: Drug: Enzalutamide
16 Active, not recruiting
Has Results
Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Bicalutamide
17 Active, not recruiting Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Condition: Breast Cancer
Interventions: Drug: enzalutamide;   Drug: anastrozole;   Drug: exemestane;   Drug: fulvestrant
18 Active, not recruiting Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: MDV3100
19 Active, not recruiting Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Conditions: Advanced or Recurrent Solid Tumors;   Breast Neoplasms;   Ovarian Cancer, Epithelial;   Ewing Sarcoma;   Small Cell Lung Carcinoma;   Prostate Cancer;   Pancreas Cancer
Intervention: Drug: Talazoparib
20 Completed A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.